🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Pembrolizumab alone and in combination with acalabrutinib in subjects with ...
Status
Completed
Location
Western Regional Medical Center/Cancer Treatment Center of America
Start Date
2015-05
Trial ID
NCT02448303
Treatments Being Tested
To characterize the safety and efficacy of acalabrutinib (ACP-196) monother...
Status
Completed
Location
Arizona Gynecology Oncology
Start Date
2015-11
Trial ID
NCT02537444
Treatments Being Tested
This study is evaluating the safety, pharmacodynamics (PD), and efficacy of...
Status
Completed
Location
Research Site
Start Date
2015-02-20
Trial ID
NCT02362035
Treatments Being Tested
ACP-196 Alone and in Combination with Pembrolizumab in Subjects with Advanc...
Status
Completed
Location
Multiple Locations
Start Date
2015-05
Trial ID
NCT02362048
Treatments Being Tested
Study of the combination of acalabrutinib (ACP-196) and pembrolizumab in su...
Status
Completed
Location
Oregon Health and Science University
Start Date
2015-05
Trial ID
NCT02454179
Treatments Being Tested
Study of the Combination of ACP-196 and Pembrolizumab in Subjects With Plat...
Status
Completed
Location
University of Chicago
Start Date
2015-04
Trial ID
NCT02351739
Treatments Being Tested